المؤلفون: Laitano R; Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy., Calzetta L; Department of Medicine and Surgery, Respiratory Disease and Lung Function Unit, University of Parma, Parma, Italy., Matino M; Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy., Pistocchini E; Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy., Rogliani P; Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy.

المصدر: Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2024 Jun; Vol. 25 (8), pp. 1071-1081. Date of Electronic Publication: 2024 Jun 16.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 100897346 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7666 (Electronic) Linking ISSN: 14656566 NLM ISO Abbreviation: Expert Opin Pharmacother Subsets: MEDLINE

مواضيع طبية MeSH: Asthma*/drug therapy , Muscarinic Antagonists*/administration & dosage , Muscarinic Antagonists*/therapeutic use , Adrenergic beta-2 Receptor Agonists*/administration & dosage , Adrenergic beta-2 Receptor Agonists*/therapeutic use , Anti-Asthmatic Agents*/administration & dosage , Anti-Asthmatic Agents*/therapeutic use , Adrenal Cortex Hormones*/administration & dosage , Adrenal Cortex Hormones*/therapeutic use , Drug Combinations*, Humans ; Administration, Inhalation ; Drug Therapy, Combination ; Severity of Illness Index ; Dose-Response Relationship, Drug

المؤلفون: Weng J; School of Public Health, Fudan University, Shanghai, China.; National Health Commission Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China., Tao Y; School of Public Health, Fudan University, Shanghai, China.; National Health Commission Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China., Xu Z; School of Public Health, Fudan University, Shanghai, China.; National Health Commission Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China., Zhou S; School of Public Health, Fudan University, Shanghai, China.; National Health Commission Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China., Xiao D; School of Public Health, Fudan University, Shanghai, China.; National Health Commission Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China., Zhu Z; School of Public Health, Fudan University, Shanghai, China.; National Health Commission Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China., Zheng R; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China., Yang Y; School of Public Health, Fudan University, Shanghai, China.; National Health Commission Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China., Chen Y; School of Public Health, Fudan University, Shanghai, China.; National Health Commission Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China.

المصدر: Journal of evidence-based medicine [J Evid Based Med] 2024 Jun; Vol. 17 (2), pp. 370-376. Date of Electronic Publication: 2024 Jun 10.

نوع المنشور: Journal Article; Systematic Review; Meta-Analysis; Comparative Study

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101497477 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1756-5391 (Electronic) Linking ISSN: 17565391 NLM ISO Abbreviation: J Evid Based Med Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/blood , Hypoglycemic Agents*/therapeutic use , Hypoglycemic Agents*/administration & dosage , Network Meta-Analysis* , Glucagon-Like Peptide-1 Receptor*/agonists , Drug Combinations*, Humans ; Glycated Hemoglobin ; Insulin, Long-Acting/therapeutic use ; Insulin, Long-Acting/administration & dosage ; Liraglutide/therapeutic use ; Liraglutide/administration & dosage

المؤلفون: Delgado-García P; IMACEN S.A. de C.V., Chihuahua, Mexico., Alcocer-Herrera JB; INBIOMEDyC Queretaro, Santiago de Querétaro, Mexico., Urenda-Quezada A; Traumatology Area of Mediadvance Clinical S.A.P.I. de C.V., Chihuahua, Mexico., Alonso-Martinez MD; Centro de Investigacion Clinica de Mexico, S. de R.L. de C.V. Morelia, Michoacan, Mexico., Bautista-Mendoza MA; Department of Traumatology and Orthopedics, Sanatorio Alcocer Pozo S.A. de C.V., Santiago de Querétaro, Mexico., Romero-Antonio Y; Research and Development Department of Laboratorios Silanes, S.A. de C.V., Av. De las Palmas No. 340, 3rd floor, Lomas de Chapultepec, Miguel Hidalgo, 11000, Mexico City, Mexico., Mora-Villalobos JC; Research and Development Department of Laboratorios Silanes, S.A. de C.V., Av. De las Palmas No. 340, 3rd floor, Lomas de Chapultepec, Miguel Hidalgo, 11000, Mexico City, Mexico., Sander-Padilla JG; Research and Development Department of Laboratorios Silanes, S.A. de C.V., Av. De las Palmas No. 340, 3rd floor, Lomas de Chapultepec, Miguel Hidalgo, 11000, Mexico City, Mexico., Rios-Brito KF; Research and Development Department of Laboratorios Silanes, S.A. de C.V., Av. De las Palmas No. 340, 3rd floor, Lomas de Chapultepec, Miguel Hidalgo, 11000, Mexico City, Mexico., Rodríguez-Vazquez IC; Research and Development Department of Laboratorios Silanes, S.A. de C.V., Av. De las Palmas No. 340, 3rd floor, Lomas de Chapultepec, Miguel Hidalgo, 11000, Mexico City, Mexico., González-Canudas J; Research and Development Department of Laboratorios Silanes, S.A. de C.V., Av. De las Palmas No. 340, 3rd floor, Lomas de Chapultepec, Miguel Hidalgo, 11000, Mexico City, Mexico. jogonzalez@silanes.com.mx.; IMSS-Centro Médico Nacional Siglo XXI, Mexico City, Mexico. jogonzalez@silanes.com.mx.

المصدر: Clinical drug investigation [Clin Drug Investig] 2024 Jun; Vol. 44 (6), pp. 413-424. Date of Electronic Publication: 2024 Jun 06.

نوع المنشور: Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III

بيانات الدورية: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1918 (Electronic) Linking ISSN: 11732563 NLM ISO Abbreviation: Clin Drug Investig Subsets: MEDLINE

مواضيع طبية MeSH: Thiamine*/administration & dosage , Thiamine*/analogs & derivatives , Thiamine*/therapeutic use , Ketoprofen*/administration & dosage , Ketoprofen*/analogs & derivatives , Pyridoxine*/administration & dosage , Pyridoxine*/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal*/administration & dosage , Vitamin B 12*/analogs & derivatives , Vitamin B 12*/administration & dosage , Vitamin B 12*/therapeutic use , Tromethamine*/administration & dosage , Drug Combinations*, Humans ; Double-Blind Method ; Female ; Adult ; Male ; Middle Aged ; Prospective Studies ; Vitamin B Complex/administration & dosage ; Vitamin B Complex/therapeutic use ; Pain Measurement/methods ; Young Adult

المؤلفون: Baldwin H, Gold LS, Harper JC, Alexis AF, Callender VD, Kircik L, Guenin E, Eichenfield LF

المصدر: Journal of drugs in dermatology : JDD [J Drugs Dermatol] 2024 Jun 01; Vol. 23 (6), pp. 394-402.

نوع المنشور: Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III

بيانات الدورية: Publisher: Physicians Continuing Education Corporation Country of Publication: United States NLM ID: 101160020 Publication Model: Print Cited Medium: Internet ISSN: 1545-9616 (Print) Linking ISSN: 15459616 NLM ISO Abbreviation: J Drugs Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Acne Vulgaris*/drug therapy , Clindamycin*/administration & dosage , Clindamycin*/adverse effects , Clindamycin*/analogs & derivatives , Gels* , Drug Combinations* , Benzoyl Peroxide*/administration & dosage , Benzoyl Peroxide*/adverse effects , Dermatologic Agents*/administration & dosage , Dermatologic Agents*/adverse effects , Quality of Life*, Humans ; Child ; Double-Blind Method ; Adolescent ; Female ; Male ; Adult ; Treatment Outcome ; Young Adult ; Administration, Cutaneous ; Severity of Illness Index

المؤلفون: Liu X; Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China., Yan Y; Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China., Lu L; Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China., Liu Y; Department of General Surgery, the Fourth Affiliated Hospital, Hebei Medical University, Shijiazhuang, China., Ma J; Department of Digestive Endoscopic and Minimally Invasive Surgery, Shanxi Cancer Hospital, Taiyuan, China., Wang X; Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China., Wang D; Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China., Liu B; Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China., Liu Z; Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China., Zhou X; Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China., Cui H; Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China., Zhao Z; Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China., Li C; Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China., Liu J; Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China., Li W; Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China., Huang QX; Department of Digestive Endoscopic and Minimally Invasive Surgery, Shanxi Cancer Hospital, Taiyuan, China., Zhao Q; Department of General Surgery, the Fourth Affiliated Hospital, Hebei Medical University, Shijiazhuang, China., Liu T; Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China., Fu W; Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.

المصدر: Cancer medicine [Cancer Med] 2024 Jun; Vol. 13 (11), pp. e7326.

نوع المنشور: Journal Article; Randomized Controlled Trial; Comparative Study

بيانات الدورية: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE

مواضيع طبية MeSH: Stomach Neoplasms*/surgery , Stomach Neoplasms*/drug therapy , Stomach Neoplasms*/pathology , Stomach Neoplasms*/mortality , Gastrectomy*/methods , Laparoscopy*/methods , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Oxaliplatin*/therapeutic use , Oxaliplatin*/administration & dosage , Tegafur*/therapeutic use , Tegafur*/administration & dosage , Drug Combinations* , Oxonic Acid*/therapeutic use , Oxonic Acid*/administration & dosage , Capecitabine*/administration & dosage , Capecitabine*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Chemotherapy, Adjuvant/methods ; Aged ; Adult

المؤلفون: Cardelli LS; Cardiology Department, Versilia Hospital, 55041 Camaiore, Italy., Magaldi M; Department of Advanced Biomedical Science, Federico II University of Naples, 80131 Napoli, Italy., Agullo A; Cardiology Department, Arnaud-De-Villeneuve Hospital, 34090 Montpellier, France., Richard G; Cardiology Department, Arnaud-De-Villeneuve Hospital, 34090 Montpellier, France., Nogue E; Inserm, IDESP, PreMedical INRIA, CHU de Montpellier, Montpellier University, 34295 Montpellier, France., Berdague P; Department of Cardiology, Béziers Hospital, 34500 Béziers, France., Galiner M; Cardiology Department, Toulouse-Rangueil University Hospital, 31400 Toulouse, France; MMP Department, Faculty of Health, Toulouse III Paul-Sabatier University, 31062 Toulouse, France., Georger F; Department of Cardiology, Béziers Hospital, 34500 Béziers, France., Picard F; Heart Failure Unit, Haut-Lévêque Hospital, 33604 Pessac, France., Prunet E; Cardiology Department, Montpellier University, Nîmes University Hospital, 30900 Nîmes, France., Molinari N; Inserm, IDESP, PreMedical INRIA, CHU de Montpellier, Montpellier University, 34295 Montpellier, France., Bourdin A; Inserm U1046, PhyMedExp, Department of Respiratory Diseases, CNRS, UMR 9214, CHU de Montpellier, University of Montpellier, 34295 Montpellier, France., Jaffuel D; Inserm U1046, PhyMedExp, Department of Respiratory Diseases, CNRS, UMR 9214, CHU de Montpellier, University of Montpellier, 34295 Montpellier, France., Roubille F; Cardiology Department, Arnaud-De-Villeneuve Hospital, 34090 Montpellier, France. Electronic address: f-roubille@chu-montpellier.fr.

المصدر: Archives of cardiovascular diseases [Arch Cardiovasc Dis] 2024 Jun-Jul; Vol. 117 (6-7), pp. 409-416. Date of Electronic Publication: 2024 May 18.

نوع المنشور: Journal Article; Observational Study; Multicenter Study

بيانات الدورية: Publisher: Elsevier Masson Country of Publication: Netherlands NLM ID: 101465655 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1875-2128 (Electronic) Linking ISSN: 18752128 NLM ISO Abbreviation: Arch Cardiovasc Dis Subsets: MEDLINE

مواضيع طبية MeSH: Valsartan*/therapeutic use , Drug Combinations* , Aminobutyrates*/therapeutic use , Aminobutyrates*/adverse effects , Ventricular Function, Right*/drug effects , Biphenyl Compounds* , Heart Failure*/physiopathology , Heart Failure*/drug therapy , Heart Failure*/diagnosis , Recovery of Function*, Humans ; Male ; Female ; Prospective Studies ; Middle Aged ; Treatment Outcome ; Aged ; Time Factors ; Sleep Apnea, Central/physiopathology ; Sleep Apnea, Central/diagnosis ; Sleep Apnea, Central/drug therapy ; Angiotensin II Type 1 Receptor Blockers/therapeutic use ; Angiotensin II Type 1 Receptor Blockers/adverse effects ; Tetrazoles/therapeutic use ; Tetrazoles/adverse effects ; Protease Inhibitors/therapeutic use ; Protease Inhibitors/adverse effects ; Polysomnography ; Neprilysin/antagonists & inhibitors ; Chronic Disease

المؤلفون: Velicki L; Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.; Institute of Cardiovascular Diseases of Vojvodina, Sremska Kamenica, Serbia., Popovic D; Cardiology Department, Faculties of Medicine and Pharmacy, University of Belgrade, Serbia., Okwose NC; Cardiovascular Research, Translational and Clinical Research and Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.; Research Centre for Health and Life Sciences, Institute of Health and Wellbeing, Faculty of Health and Life Science, Coventry University, Coventry, UK., Preveden A; Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.; Institute of Cardiovascular Diseases of Vojvodina, Sremska Kamenica, Serbia., Tesic M; Cardiology Department, Faculties of Medicine and Pharmacy, University of Belgrade, Serbia., Tafelmeier M; Department of Internal Medicine II, University Medical Centre Regensburg, Regensburg, Germany., Charman SJ; Cardiovascular Research, Translational and Clinical Research and Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Barlocco F; Careggi University Hospital, University of Florence, Florence, Italy., MacGowan GA; Cardiovascular Research, Translational and Clinical Research and Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Seferovic PM; Cardiology Department, Faculties of Medicine and Pharmacy, University of Belgrade, Serbia., Filipovic N; Bioengineering Research and Development Center, BioIRC, Kragujevac, Serbia.; Faculty of Engineering, University of Kragujevac, Kragujevac, Serbia., Ristic A; Cardiology Department, Faculties of Medicine and Pharmacy, University of Belgrade, Serbia., Olivotto I; Careggi University Hospital, University of Florence, Florence, Italy., Maier LS; Department of Internal Medicine II, University Medical Centre Regensburg, Regensburg, Germany., Jakovljevic DG; Cardiovascular Research, Translational and Clinical Research and Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.; Research Centre for Health and Life Sciences, Institute of Health and Wellbeing, Faculty of Health and Life Science, Coventry University, Coventry, UK.; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

مؤلفون مشاركون: SILICOFCM Investigators

المصدر: European journal of heart failure [Eur J Heart Fail] 2024 Jun; Vol. 26 (6), pp. 1361-1368. Date of Electronic Publication: 2024 May 27.

نوع المنشور: Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0844 (Electronic) Linking ISSN: 13889842 NLM ISO Abbreviation: Eur J Heart Fail Subsets: MEDLINE

مواضيع طبية MeSH: Valsartan* , Biphenyl Compounds* , Aminobutyrates*/therapeutic use , Drug Combinations* , Cardiomyopathy, Hypertrophic*/drug therapy , Cardiomyopathy, Hypertrophic*/physiopathology , Angiotensin Receptor Antagonists*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Stroke Volume/physiology ; Oxygen Consumption/drug effects ; Aged ; Tetrazoles/therapeutic use ; Echocardiography/methods ; Treatment Outcome ; Quality of Life ; Heart Failure/drug therapy ; Heart Failure/physiopathology

المؤلفون: Zeyu Z; Department of Cardiovascular, the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300381, China., Zhuangzhuang J; Department of Cardiovascular, the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300381, China., Yuwei S; Department of Cardiovascular, the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300381, China., Xuan Z; Department of Cardiovascular, the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300381, China., Ci W; Department of Cardiovascular, the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300381, China., Shuai W; Department of Cardiovascular, the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300381, China., Peipei Z; Department of Cardiovascular, the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300381, China., Qiuan R; Department of Cardiovascular, the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300381, China., Xianliang W; Department of Cardiovascular, the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300381, China., Jingyuan M; Department of Cardiovascular, the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300381, China.

المصدر: Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan [J Tradit Chin Med] 2024 Jun; Vol. 44 (3), pp. 448-457.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Academy Of Traditional Chinese Medicine Country of Publication: China NLM ID: 8211546 Publication Model: Print Cited Medium: Internet ISSN: 2589-451X (Electronic) Linking ISSN: 02552922 NLM ISO Abbreviation: J Tradit Chin Med Subsets: MEDLINE

مواضيع طبية MeSH: Drugs, Chinese Herbal*/administration & dosage , Rats, Sprague-Dawley* , Heart Failure*/drug therapy , Heart Failure*/genetics , Heart Failure*/metabolism , Heart Failure*/physiopathology , Heart Failure*/etiology , Fibrosis*/drug therapy , Drug Combinations*, Animals ; Rats ; Male ; Humans ; Myocardium/metabolism ; Myocardium/pathology ; Extracellular Signal-Regulated MAP Kinases/metabolism ; Extracellular Signal-Regulated MAP Kinases/genetics ; MAP Kinase Signaling System/drug effects ; Mitogen-Activated Protein Kinase Kinases/metabolism ; Mitogen-Activated Protein Kinase Kinases/genetics ; Signal Transduction/drug effects ; Sarcoma/drug therapy ; Sarcoma/genetics ; Sarcoma/metabolism

المؤلفون: Ford JL; Janssen Research & Development, Spring House, Pennsylvania, USA., Sabet A; ICON, Salt Lake City, Utah, USA., Natarajan J; Janssen Research & Development, Raritan, New Jersey, USA., Stieltjes H; Janssen Research & Development, Beerse, Belgium., Chao DL; Janssen Research & Development, Raritan, New Jersey, USA., Goyal N; Janssen Research & Development, Raritan, New Jersey, USA., Csonka D; Actelion Pharmaceuticals, A Janssen Pharmaceutical Company of Johnson & Johnson, Allschwil, Switzerland.

المصدر: Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Jun; Vol. 12 (3), pp. e1202.

نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I; Comparative Study

بيانات الدورية: Publisher: John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics Country of Publication: United States NLM ID: 101626369 Publication Model: Print Cited Medium: Internet ISSN: 2052-1707 (Electronic) Linking ISSN: 20521707 NLM ISO Abbreviation: Pharmacol Res Perspect Subsets: MEDLINE

مواضيع طبية MeSH: Therapeutic Equivalency* , Cross-Over Studies* , Pyrimidines*/pharmacokinetics , Pyrimidines*/administration & dosage , Pyrimidines*/blood , Food-Drug Interactions* , Tablets* , Tadalafil*/pharmacokinetics , Tadalafil*/administration & dosage , Tadalafil*/blood , Drug Combinations* , Healthy Volunteers* , Sulfonamides*/pharmacokinetics , Sulfonamides*/administration & dosage , Sulfonamides*/blood , Area Under Curve*, Humans ; Male ; Adult ; Young Adult ; Female ; Middle Aged ; Administration, Oral ; Fasting ; Adolescent

المؤلفون: Kovoor JG; Westmead Applied Research Centre, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.; Ballarat Base Hospital, Ballarat, VIC, Australia., Chow CK; Westmead Applied Research Centre, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.; Westmead Hospital, Sydney, NSW, Australia.; The George Institute for Global Health, UNSW, Sydney, NSW, Australia., Salam A; The George Institute for Global Health, UNSW, Sydney, NSW, Australia.; The George Institute for Global Health, Hyderabad, Telangana, India.; Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, India., Webster R; The George Institute for Global Health, UNSW, Sydney, NSW, Australia.; School of Population Health, UNSW, Sydney, NSW, Australia., Shiel L; School of Public Health and Preventive Medicine, Monash University, Prahran, VIC, Australia., Nelson MR; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia., Affandi JS; Curtin School of Population Health, Curtin University, Perth, WA, Australia., Hay P; Castle Hill Medical Centre, Sydney, NSW, Australia., Burke M; Kildare Road Medical Centre, Sydney, NSW, Australia., Figtree GA; Kolling Institute, Royal North Shore Hospital, Sydney, NSW, Australia.; Charles Perkins Centre, University of Sydney, Sydney, NSW, Australia., Usherwood T; Westmead Applied Research Centre, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.; The George Institute for Global Health, UNSW, Sydney, NSW, Australia., Reid CM; Curtin School of Population Health, Curtin University, Perth, WA, Australia., Schlaich MP; Dobney Hypertension Centre, Medical School - Royal Perth Hospital Unit and RPH Research Foundation, The University of Western Australia, Perth, WA, Australia., Rodgers A; Westmead Applied Research Centre, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.; The George Institute for Global Health, UNSW, Sydney, NSW, Australia., Atkins ER; The George Institute for Global Health, UNSW, Sydney, NSW, Australia. emily.atkins@unsw.edu.au.

المصدر: Journal of human hypertension [J Hum Hypertens] 2024 Jun; Vol. 38 (6), pp. 516-522. Date of Electronic Publication: 2024 May 14.

نوع المنشور: Journal Article; Randomized Controlled Trial; Multicenter Study

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8811625 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5527 (Electronic) Linking ISSN: 09509240 NLM ISO Abbreviation: J Hum Hypertens Subsets: MEDLINE

مواضيع طبية MeSH: Hypertension*/drug therapy , Hypertension*/physiopathology , Hypertension*/diagnosis , Antihypertensive Agents*/administration & dosage , Drug Combinations* , Blood Pressure*/drug effects, Humans ; Female ; Male ; Middle Aged ; Aged ; Treatment Outcome ; Patient Preference ; Adult